Lin, J <br/><br/>
HIF-1alpha and calcium signaling as targets for treatment of prostate cancer by cardiac glycosides.  [electronic resource] 

 -  Current cancer drug targets  Nov 2009 
 - 881-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1873-5576 
<br/><br/><label>Standard No.: </label>10.2174/156800909789760249  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Calcium Signaling--drug effects<br/>Cardiac Glycosides--pharmacology<br/>Clinical Trials as Topic<br/>Drug Delivery Systems<br/>Humans<br/>Hypoxia--metabolism<br/>Hypoxia-Inducible Factor 1, alpha Subunit--antagonists & inhibitors<br/>Male<br/>Models, Biological<br/>Prostatic Neoplasms--drug therapy<br/>Receptor Cross-Talk<br/>Receptors, Androgen--metabolism<br/>Signal Transduction--drug effects